Home  /  Resource Library  /  CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A Real-World Analysis of Patterns of Failure and Role of Bridging Therapy

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A Real-World Analysis of Patterns of Failure and Role of Bridging Therapy

ASH 2020: Study examined the effectiveness and outcomes of CAR T-cell therapy for treatment of relapsed DLBCL in the real world.